Parameters of the Recovery Time of Acute Kidney Injury in Critically Ill Patients
Launched by ASSIUT UNIVERSITY · Nov 1, 2023
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how long it takes for critically ill patients with Acute Kidney Injury (AKI) to recover. The researchers want to find out what factors might influence this recovery time, including the patients' age, gender, existing health conditions, and even their emotional well-being, like feelings of depression or anxiety. By looking at these different aspects, the study aims to help improve care for patients in the intensive care unit (ICU) who are facing AKI.
To be eligible for this study, participants need to be adults aged 18 or older who have been admitted to the ICU for at least 24 hours and have experienced AKI. Unfortunately, younger patients and those who do not wish to participate cannot join. Although the study is not yet recruiting participants, those who do take part can expect to have their health and recovery closely monitored, which may help improve treatments for future patients with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1:adult patients (age ≥ 18 years) who admitted to the ICU for at least 24 hours and experience AKI
- Exclusion Criteria:
- • 1. patients (age \<18 years)
- • 2. Patient who refuse enter study Patient
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported